Nasdaq: MRNA
Moderna insiders
The officers, directors and 10% owners of Moderna, Inc. who hold the most stock, valued at the live MRNA price.
$199.33
MRNA today +$2.5M (+1.29%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 13
- Their MRNA stock
- $4.48B
- Market value
- $81.19B
- Held by ranked insiders
- 5.51%
Insiders by value of MRNA holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Robert Langer | Director | 11,481,093 | $2.29B | 2.82% | 136th |
| 2 | Stephane Bancel | Chief Executive Officer | 6,440,260 | $1.28B | 1.58% | 211th |
| 3 | Noubar B. Afeyan | Director | 2,227,939 | $444M | 0.55% | 520th |
| 4 | Stephen Hoge | President | 1,467,144 | $292M | 0.36% | 692nd |
| 5 | Paul Sagan | Director | 494,133 | $98.5M | 0.12% | 1522nd |
| 6 | Juan Andres | Chief Operating Officer | 125,000 | $24.9M | <0.1% | 4255th |
| 7 | Shannon Thyme Klinger | Chief Legal Officer | 81,340 | $16.2M | <0.1% | 6047th |
| 8 | James M. Mock | Chief Financial Officer | 60,125 | $12.0M | <0.1% | 6059th |
| 9 | Francois Nader | Director | 32,781 | $6.5M | <0.1% | 11982nd |
| 10 | Elizabeth G. Nabel | Director | 19,317 | $3.9M | <0.1% | 13050th |
| 11 | Sandra Horning | Director | 18,585 | $3.7M | <0.1% | 5116th |
| 12 | David M. Rubenstein | Director | 9,643 | $1.9M | <0.1% | 269th |
| 13 | Elizabeth E. Tallett | Director | 4,761 | $949K | <0.1% | 14480th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Moderna; see each profile for the filing.